The Psychedelic Medicine Task Force was created to survey the research on potential therapeutic uses of hallucinogens like LSD, MDMA and psilocybin mushrooms
Speaking of the “Magic Mushroom” chocolate bars in question, store management said, “[the DEA] … had done their own lab testing on the products and some … did not pass their standards.”
On the cost of psilocybin, adult versus medical programs, and FDA developments. Based on “interviews with facilitators, service center owners, manufacturers, researchers and policymakers in Oregon.”
How a product like mushroom gummies can fall through the regulatory cracks
Founder of Connecticut for Accessible Psychedelic Medicine tells TJM: “When people see that their own lives can improve, it builds a community [that] is willing to fight.”
And one lawmaker decries deception but vows to “continue to work with grassroots advocates, veterans, mental health professionals, addiction specialists and a growing coalition of supporters”
Veteran impersonation act outrages activists, further muddies grassroots waters
Advocates decry “shadow campaign” subverting ballot initiative to legalize psychedelics in Massachusetts
“We knew we wanted to do something in psychedelics as we believed [Amanita muscaria] could be disruptive to the existing medicinal landscape.”
From generating buzz around their cause to getting heard on Beacon Hill, psychedelics advocates had a big March. But underneath the wins, fractures in the movement as well as external opposition could undermine legalization efforts.
